176 V. Marzo et al.
deLagoE,deMiguelR,Lastres-BeckerI,RamosJA,Fernández-RuizJ(2004a)Involvementof
vanilloid-likereceptorsintheeffectsofanandamideonmotorbehaviorandnigrostriatal
dopaminergic activity: in vivo and in vitro evidence. Brain Res 1007:152–159
deLagoE,LigrestiA,OrtarG,MoreraE,CabranesA,PryceG,BifulcoM,BakerD,Fernandez-
Ruiz J, Di Marzo V (2004b) In vivo pharmacological actions of two novel inhibitors of
anandamide cellular uptake. Eur J Pharmacol 484:249–257
De Petrocellis L, Melck D, Ueda N, Maurelli S, Kurahashi Y, Yamamoto S, Marino G, Di
Marzo V (1997) Novel inhibitors of brain, neuronal, and basophilic anandamide ami-
dohydrolase. Biochem Biophys Res Commun 231:82–88
De Petrocellis L, Bisogno T, Davis JB, Pertwee RG, Di Marzo V (2000) Overlap between
the ligand recognition properties of the anandamide transporter and the VR1 vanilloid
receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS
Lett 483:52–56
De Petrocellis L, Bisogno T, Maccarrone M, Davis JB, Finazzi-Agrò A, Di Marzo V (2001) The
activity of anandamide at vanilloid VR1 receptors requires facilitated transport across
the cell membrane and is limited by intracellular metabolism. J Biol Chem 276:12856–
12863
Denovan-Wright EM, Robertson HA (2000) Cannabinoid receptor messenger RNA levels
decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of
transgenic Huntington’s disease mice. Neuroscience 98:705–713
Deutsch DG, Lin S, Hill WA, Morse KL, Salehani D, Arreaza G, Omeir RL, Makriyannis A
(1997a) Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the
cannabinoid receptor. Biochem Biophys Res Commun 231:217–221
Deutsch DG, Omeir R, Arreaza G, Salehani D, Prestwich GD, Huang Z, Howlett A (1997b)
Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide
amidase. Biochem Pharmacol 53:255–260
Deutsch DG, Glaser ST, Howell JM, Kunz JS, Puffenbarger RA, Hillard CJ, Abumrad N
(2001) The cellular uptake of anandamide is coupled to its breakdown by fatty-acid
amide hydrolase. J Biol Chem 276:6967–6973
DeutschDG,UedaN,YamamotoS(2002)Thefattyacidamidehydrolase(FAAH).Prostaglan-
dins Leukot Essent Fatty Acids 66:201–210
DevaneWA,HanusL,BreuerA,PertweeRG,StevensonLA,GriffinG,GibsonD,Mandelbaum
A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that
binds to the cannabinoid receptor. Science 258:1946–1949
Di Marzo V, Fontana A (1995) Anandamide, an endogenous cannabinomimetic eicosanoid:
’killing two birds with one stone’. Prostaglandins Leukot Essent Fatty Acids 53:1–11
Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, Piomelli D (1994)
Formationandinactivationofendogenouscannabinoidanandamideincentralneurons.
Nature 372:686–691
Di Marzo V, De Petrocellis L, Sepe N, Buono A (1996a) Biosynthesis of anandamide and
related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells.
Biochem J 316:977–984
Di Marzo V, De Petrocellis L, Sugiura T, Waku K (1996b) Potential biosynthetic connec-
tions between the two cannabimimetic eicosanoids, anandamide and 2-arachidonoyl-
glycerol, in mouse neuroblastoma cells. Biochem Biophys Res Commun 227:281–288
Di Marzo V, Bisogno T, Sugiura T, Melck D, De Petrocellis L (1998a) The novel endogenous
cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells:
connections with anandamide. Biochem J 331:15–19
Di Marzo V, Melck D, Bisogno T, De Petrocellis L (1998b) Endocannabinoids: endogenous
cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci 21:521–
528
Di Marzo V, Bisogno T, De Petrocellis L, Melck D, Orlando P, Wagner JA, Kunos G (1999a)
Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circu-
lating and tumoral macrophages. Eur J Biochem 264:258–267